Receptor, Muscarinic M3

"Receptor, Muscarinic M3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.


expand / collapse Publications
This graph shows the total number of publications written about "Receptor, Muscarinic M3" by people in this website by year, and whether "Receptor, Muscarinic M3" was a major or minor topic of these publications.
Below are the most recent publications written about "Receptor, Muscarinic M3" by people in Profiles.
  1. An Updated Structure of Oxybutynin Hydrochloride. Adv Sci (Weinh). 2024 Oct; 11(40):e2406494.
    View in: PubMed
  2. Acetylcholine Engages Distinct Amygdala Microcircuits to Gate Internal Theta Rhythm. J Neurosci. 2024 Apr 24; 44(17).
    View in: PubMed
  3. Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances. Curr Neuropharmacol. 2023; 21(3):740-760.
    View in: PubMed
  4. The M3 Muscarinic Acetylcholine Receptor Promotes Epidermal Differentiation. J Invest Dermatol. 2022 12; 142(12):3211-3221.e2.
    View in: PubMed
  5. Negative feedback control of neuronal activity by microglia. Nature. 2020 10; 586(7829):417-423.
    View in: PubMed
  6. Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis. Oncogene. 2020 05; 39(20):4014-4027.
    View in: PubMed
  7. Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris. Int Immunopharmacol. 2020 Mar; 80:106149.
    View in: PubMed
  8. Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists. Proc Natl Acad Sci U S A. 2018 11 20; 115(47):12046-12050.
    View in: PubMed
  9. Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018; 13:1873-1888.
    View in: PubMed
  10. Breakpoint mapping and haplotype analysis of translocation t(1;12)(q43;q21.1) in two apparently independent families with vascular phenotypes. Mol Genet Genomic Med. 2018 01; 6(1):56-68.
    View in: PubMed